BioWorld Asia

Jan. 9, 2002

View Archived Issues

PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback

New Heart Drugs Could Be Hiding In A Glass Of Vin Rouge

NeuTec Raising 10M To Fund Programs Targeting Infections

Budget Cuts Sidetrack Plan For Israeli Biotech Institute

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Novartis Enlists Optimata To Analyze New Drug Candidates

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

ExonHit Partners With IDEC To Develop Antibody Therapeutics

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma. Read More

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for April 10, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for April 7, 2026

MMP inhibitors divulged in Accure Therapeutics patent

BioWorld Science

Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...

MSD discloses new HCN1/2 blockers

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...

Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

BioWorld Science

Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...